sibutramine has been researched along with Hyperlipemia in 6 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
| Excerpt | Relevance | Reference |
|---|---|---|
| "In overweight and obese patients with high serum triglyceride levels and low serum HDL-C levels, treatment with sibutramine was associated with significant improvements in body weight and in serum triglyceride and HDL-C levels." | 9.09 | Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia. ( Dujovne, CA; Mendel, CM; Rowe, E; Zavoral, JH, 2001) |
| "To investigate, through a meta-analysis of clinical trials, the effect of two weight-reducing drugs, such as orlistat and sibutramine, on serum lipid profiles in overweight and obese subjects, independently of weight loss." | 8.84 | Orlistat and sibutramine beyond weight loss. ( Dicembrini, I; Mannucci, E; Rotella, CM; Rotella, F, 2008) |
| "Among methods of treatment of obesity the most known and safe is the low calories content diet." | 6.42 | [Sibutramine in treatment of obesity. Therapeutic premises in patients with essential hypertension, diabetes, hyperlipidemia]. ( Kawecka-Jaszcz, K; Rajzer, M; Wojciechowska, W, 2004) |
| "In overweight and obese patients with high serum triglyceride levels and low serum HDL-C levels, treatment with sibutramine was associated with significant improvements in body weight and in serum triglyceride and HDL-C levels." | 5.09 | Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia. ( Dujovne, CA; Mendel, CM; Rowe, E; Zavoral, JH, 2001) |
| "To investigate, through a meta-analysis of clinical trials, the effect of two weight-reducing drugs, such as orlistat and sibutramine, on serum lipid profiles in overweight and obese subjects, independently of weight loss." | 4.84 | Orlistat and sibutramine beyond weight loss. ( Dicembrini, I; Mannucci, E; Rotella, CM; Rotella, F, 2008) |
| "Among methods of treatment of obesity the most known and safe is the low calories content diet." | 2.42 | [Sibutramine in treatment of obesity. Therapeutic premises in patients with essential hypertension, diabetes, hyperlipidemia]. ( Kawecka-Jaszcz, K; Rajzer, M; Wojciechowska, W, 2004) |
| "Sibutramine is a centrally acting inhibitor of noradrenaline and serotonine reuptake, thereby decreasing caloric intake and increasing energy expenditure." | 2.41 | Current pharmacological approaches to the treatment of obesity. ( Hauner, H, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajzer, M | 1 |
| Wojciechowska, W | 1 |
| Kawecka-Jaszcz, K | 1 |
| Mannucci, E | 1 |
| Dicembrini, I | 1 |
| Rotella, F | 1 |
| Rotella, CM | 1 |
| Bodary, PF | 1 |
| Iglay, HB | 1 |
| Eitzman, DT | 1 |
| Hauner, H | 1 |
| Dujovne, CA | 1 |
| Zavoral, JH | 1 |
| Rowe, E | 1 |
| Mendel, CM | 1 |
| Eisenberg, D | 1 |
4 reviews available for sibutramine and Hyperlipemia
| Article | Year |
|---|---|
[Sibutramine in treatment of obesity. Therapeutic premises in patients with essential hypertension, diabetes, hyperlipidemia].
Topics: Animals; Appetite Depressants; Clinical Trials as Topic; Cyclobutanes; Developed Countries; Diabetes | 2004 |
Orlistat and sibutramine beyond weight loss.
Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Cardiovascular Diseases; Cyclobutanes; Humans; Hyp | 2008 |
Strategies to reduce vascular risk associated with obesity.
Topics: Adiponectin; Anti-Obesity Agents; Cardiovascular Diseases; Cyclobutanes; Diabetes Mellitus, Type 2; | 2007 |
Current pharmacological approaches to the treatment of obesity.
Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Diabetes Mellitus, Type 2; Humans; Hyperlip | 2001 |
1 trial available for sibutramine and Hyperlipemia
| Article | Year |
|---|---|
Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
Topics: Adolescent; Adult; Aged; Appetite Depressants; Body Weight; Cyclobutanes; Double-Blind Method; Femal | 2001 |
1 other study available for sibutramine and Hyperlipemia
| Article | Year |
|---|---|
Risk factor modification through weight loss enhanced with pharmacotherapy.
Topics: Appetite Depressants; Body Weight; Clinical Trials as Topic; Cyclobutanes; Humans; Hyperlipidemias; | 2002 |